PlasFree
Nazareth · Founded 2017
About PlasFree
PlasFree focuses on the development of ClearPlasma, a medical device that modifies human plasma to improve treatment for massive bleeding. ClearPlasma extracts fibrinolytic proteins that are responsible for dissolving blood clots. It modifies the human plasma generating improved plasma that is more prone to coagulation. PlasFree's product aims to revolutionize the treatment of massive bleeding and to enable safe and effective treatment to massive bleeding around the world. PlasFree was founded in 2017 and is headquartered in Nazareth, Israel.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Grant (Oct 2021)
- Website: http://www.plas-free.com
- Phone: +972-4-609-8615
Industries & Categories
Health Care, Manufacturing, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/plasfree-121302 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.